Samaneh Saghafian Larijani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Samaneh Saghafian Larijani has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Hosna Mirfakhraee
Department of Internal Medicine, Firoozabadi Clinical Research Development Unit, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
4 shared publications - Maryam Niksolat
Department of Geriatric Medicine, Geriatric Mental Health Research Center, Firoozabadi Clinical Research Development Unit (FACRDU), School of Medicine, Iran University of Medical Sciences, Tehran, Iran
4 shared publications - Maryam Biglari Abhari
Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Community and Family Medicine Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2 shared publications - Roya Biglarifar
Department of Obstetrics and Gynecology, School of Medicine, Iran University of Medical Sciences: Tehran, Iran
2 shared publications - Zhale Zandieh
Department of Ageing, Assistant Professor of Geriatric Medicine, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
2 shared publications - Adnan Tizmaghz
Breast Cancer Research Center, Iran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- 1 December 2025
- Published by Maad Rayan Publishing Company in Journal of Preventive Epidemiology
- Vol. 11 (1) , e39291
Comparative analysis of umbilical cord arterial blood gas parameters in vaginal delivery with and without epidural analgesia; a prospective case-control study
Introduction: Epidural analgesia is a widely accepted and effective method for labor pain relief, though its impact on neonatal outcomes continues to be extensively studied. Key measures such as umbilical cord arterial blood gas (ABG) parameters, including pH and base excess (BE), provide valuable, objective indications of the newborn’s metabolic status immediately after birth. Objectives: This study aimed to assess the physiological safety of epidural analgesia for both mother and neonate during vaginal delivery, thereby contributing to a clearer understanding of its clinical implications and neonatal well-being. Patients and Methods: This prospective case-control study included 80 women referred to Firoozabadi hospital between September 2024 and August 2025, divided into two equal groups (n = 40) based on labor pain management: epidural analgesia and vaginal delivery without pain relief. All deliveries were conducted by a single gynecologist using a standardized protocol, and epidural analgesia was administered by a single anesthesiologist following a uniform method. Data collection involved obtaining informed consent, recording demographic and clinical data, assessing neonatal Apgar scores at birth, and measuring umbilical cord ABG parameters (pH and BE) immediately after delivery. All data were compared between the two groups using statistical tests. Results: The results revealed no significant differences between the control and epidural analgesia groups in demographic characteristics such as age and body mass index (BMI), nor in clinical outcomes, including Apgar scores. Additionally, umbilical cord ABG parameters, specifically pH and BE values, were comparable between the groups, indicating no meaningful impact of epidural analgesia on maternal or neonatal acid-base status. Conclusion: The results indicated that the epidural analgesia during vaginal delivery does not significantly impact maternal or neonatal acid-base status, and these findings confirm the safety of epidural analgesia as an effective pain relief method that does not compromise key physiological measures of metabolic health.
- 1 December 2025
- Published by Maad Rayan Publishing Company in Journal of Preventive Epidemiology
- Vol. 11 (1) , e39291
Comparative analysis of umbilical cord arterial blood gas parameters in vaginal delivery with and without epidural analgesia; a prospective case-control study
Introduction: Epidural analgesia is a widely accepted and effective method for labor pain relief, though its impact on neonatal outcomes continues to be extensively studied. Key measures such as umbilical cord arterial blood gas (ABG) parameters, including pH and base excess (BE), provide valuable, objective indications of the newborn’s metabolic status immediately after birth. Objectives: This study aimed to assess the physiological safety of epidural analgesia for both mother and neonate during vaginal delivery, thereby contributing to a clearer understanding of its clinical implications and neonatal well-being. Patients and Methods: This prospective case-control study included 80 women referred to Firoozabadi hospital between September 2024 and August 2025, divided into two equal groups (n = 40) based on labor pain management: epidural analgesia and vaginal delivery without pain relief. All deliveries were conducted by a single gynecologist using a standardized protocol, and epidural analgesia was administered by a single anesthesiologist following a uniform method. Data collection involved obtaining informed consent, recording demographic and clinical data, assessing neonatal Apgar scores at birth, and measuring umbilical cord ABG parameters (pH and BE) immediately after delivery. All data were compared between the two groups using statistical tests. Results: The results revealed no significant differences between the control and epidural analgesia groups in demographic characteristics such as age and body mass index (BMI), nor in clinical outcomes, including Apgar scores. Additionally, umbilical cord ABG parameters, specifically pH and BE values, were comparable between the groups, indicating no meaningful impact of epidural analgesia on maternal or neonatal acid-base status. Conclusion: The results indicated that the epidural analgesia during vaginal delivery does not significantly impact maternal or neonatal acid-base status, and these findings confirm the safety of epidural analgesia as an effective pain relief method that does not compromise key physiological measures of metabolic health.
- 25 August 2025
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 15 (1) , e38679
Risk prediction for preeclampsia in pregnant women with chronic kidney disease
Preeclampsia can have long-term effects on kidney function in women with chronic kidney disease (CKD). Women with a history of preeclampsia have an increased risk of CKD and end-stage renal disease (ESRD) later in life. Regular check-ups are needed for preeclamptic women, especially those with persistent hypertension or proteinuria. Therefore, prediction models incorporating renal function and pregnancy outcomes in the first trimester can help assess pregnancy risk in CKD patients. Risk stratification models consider disease activity, major organ involvement, maternal risk factors and comorbidities, previous pregnancy complications, teratogenic drugs, and laboratory tests.
- 25 August 2025
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 15 (1) , e38679
Risk prediction for preeclampsia in pregnant women with chronic kidney disease
Preeclampsia can have long-term effects on kidney function in women with chronic kidney disease (CKD). Women with a history of preeclampsia have an increased risk of CKD and end-stage renal disease (ESRD) later in life. Regular check-ups are needed for preeclamptic women, especially those with persistent hypertension or proteinuria. Therefore, prediction models incorporating renal function and pregnancy outcomes in the first trimester can help assess pregnancy risk in CKD patients. Risk stratification models consider disease activity, major organ involvement, maternal risk factors and comorbidities, previous pregnancy complications, teratogenic drugs, and laboratory tests.
- Open Access
- 9 August 2025
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 13, e13297
Adverse side effects of maternal levothyroxine consumption in pregnant women with subclinical hypothyroidism: a systematic review study
Introduction: Subclinical hypothyroidism (SCH) during pregnancy is a prevalent endocrine disorder, often managed with levothyroxine therapy. Although levothyroxine (LT4) is widely prescribed to mitigate potential risks associated with SCH, concerns persist regarding its safety profile and possible adverse effects on pregnancy outcomes. This systematic review evaluates the current evidence on the adverse maternal, fetal, and neonatal outcomes linked to levothyroxine use in pregnant women diagnosed with SCH. Materials and Methods: This systematic review was conducted on original research studies published between 2015 and 2025 that evaluated the adverse effects of levothyroxine use in pregnant women with SCH. Comprehensive searches were performed across PubMed, Web of Science, Scopus, Embase, Cochrane Library, and Google Scholar. Data extraction was independently performed by two reviewers using a standardized checklist, with a third reviewer resolving any discrepancies. Results: The systematic review encompassed 12 studies totaling 1,952,592 participants (20,010 treated with LT4; 1,932,582 untreated). Preterm labor was the most frequent adverse outcome (reported in six studies), followed by gestational diabetes (three studies). Small-for-gestational-age (SGA) infants, low birth weight (LBW), and preeclampsia each appeared in two studies. Other effects, seizures in children, inadequate gestational weight gain, infant death, premature rupture of membranes, fetal macrosomia, and postpartum hemorrhage, were each noted once. Two studies found no adverse effects. Conclusion: This review study highlights preterm labor as the most common adverse outcome of LT4 use in pregnancy, followed by gestational diabetes. Repeated observations of SGA infants, LBW, and preeclampsia further highlight risks to fetal growth and maternal health. Less common but serious complications, such as seizures, inadequate weight gain, infant death, premature membrane rupture, fetal macrosomia, and postpartum hemorrhage, were each noted once, while two studies found no adverse effects, indicating that risk may depend on study factors, patient populations. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420251105434) and Research Registry (UIN: reviewregistry2025) websites.
- 9 August 2025
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 13, e13297
Open AccessAdverse side effects of maternal levothyroxine consumption in pregnant women with subclinical hypothyroidism: a systematic review study
Introduction: Subclinical hypothyroidism (SCH) during pregnancy is a prevalent endocrine disorder, often managed with levothyroxine therapy. Although levothyroxine (LT4) is widely prescribed to mitigate potential risks associated with SCH, concerns persist regarding its safety profile and possible adverse effects on pregnancy outcomes. This systematic review evaluates the current evidence on the adverse maternal, fetal, and neonatal outcomes linked to levothyroxine use in pregnant women diagnosed with SCH. Materials and Methods: This systematic review was conducted on original research studies published between 2015 and 2025 that evaluated the adverse effects of levothyroxine use in pregnant women with SCH. Comprehensive searches were performed across PubMed, Web of Science, Scopus, Embase, Cochrane Library, and Google Scholar. Data extraction was independently performed by two reviewers using a standardized checklist, with a third reviewer resolving any discrepancies. Results: The systematic review encompassed 12 studies totaling 1,952,592 participants (20,010 treated with LT4; 1,932,582 untreated). Preterm labor was the most frequent adverse outcome (reported in six studies), followed by gestational diabetes (three studies). Small-for-gestational-age (SGA) infants, low birth weight (LBW), and preeclampsia each appeared in two studies. Other effects, seizures in children, inadequate gestational weight gain, infant death, premature rupture of membranes, fetal macrosomia, and postpartum hemorrhage, were each noted once. Two studies found no adverse effects. Conclusion: This review study highlights preterm labor as the most common adverse outcome of LT4 use in pregnancy, followed by gestational diabetes. Repeated observations of SGA infants, LBW, and preeclampsia further highlight risks to fetal growth and maternal health. Less common but serious complications, such as seizures, inadequate weight gain, infant death, premature membrane rupture, fetal macrosomia, and postpartum hemorrhage, were each noted once, while two studies found no adverse effects, indicating that risk may depend on study factors, patient populations. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420251105434) and Research Registry (UIN: reviewregistry2025) websites.
- Open Access
- 8 March 2025
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 14 (4) , e38440
The correlation between serum sodium levels and preeclampsia severity in pregnant women; a cross-sectional study
Introduction: Preeclampsia is a significant pregnancy complication characterized by hypertension and proteinuria, potentially leading to severe maternal and fetal morbidity. The pathophysiology of preeclampsia involves endothelial dysfunction, which may influence various biochemical markers, including serum sodium levels. Objectives: This study aims to elucidate the relationship between serum sodium concentrations and preeclampsia severity. Patients and Methods: This cross-sectional study was conducted in 2023 on 112 pregnant women diagnosed with preeclampsia at Akbarabadi and Firoozabadi hospitals in Tehran. Participants were categorized into mild/moderate and severe preeclampsia groups based on clinical criteria. Data collection utilized a researcher-designed checklist that included demographic information such as maternal age and body mass index (BMI), as well as clinical details including delivery type, twin status, proteinuria levels, blood pressure, maternal sodium concentrations measured before and up to 48 hours post-delivery, gestational age, and fetal weight. The primary outcome was evaluating the correlation between maternal serum sodium levels and the severity of preeclampsia. Results: The study involved 112 women with an average age of 29.37 ± 6.33 years, among whom 57 were diagnosed with severe preeclampsia and 55 with mild or moderate cases. The analysis revealed that there was no statistically significant correlation between serum sodium levels and the severity of preeclampsia (P>0.05). Conclusion: The findings suggest that serum sodium levels may not be a reliable biomarker for assessing the severity of preeclampsia in pregnant women, highlighting the need for further research to explore other potential indicators that could better reflect the condition’s severity and inform clinical management strategies.
- 8 March 2025
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 14 (4) , e38440
Open AccessThe correlation between serum sodium levels and preeclampsia severity in pregnant women; a cross-sectional study
Introduction: Preeclampsia is a significant pregnancy complication characterized by hypertension and proteinuria, potentially leading to severe maternal and fetal morbidity. The pathophysiology of preeclampsia involves endothelial dysfunction, which may influence various biochemical markers, including serum sodium levels. Objectives: This study aims to elucidate the relationship between serum sodium concentrations and preeclampsia severity. Patients and Methods: This cross-sectional study was conducted in 2023 on 112 pregnant women diagnosed with preeclampsia at Akbarabadi and Firoozabadi hospitals in Tehran. Participants were categorized into mild/moderate and severe preeclampsia groups based on clinical criteria. Data collection utilized a researcher-designed checklist that included demographic information such as maternal age and body mass index (BMI), as well as clinical details including delivery type, twin status, proteinuria levels, blood pressure, maternal sodium concentrations measured before and up to 48 hours post-delivery, gestational age, and fetal weight. The primary outcome was evaluating the correlation between maternal serum sodium levels and the severity of preeclampsia. Results: The study involved 112 women with an average age of 29.37 ± 6.33 years, among whom 57 were diagnosed with severe preeclampsia and 55 with mild or moderate cases. The analysis revealed that there was no statistically significant correlation between serum sodium levels and the severity of preeclampsia (P>0.05). Conclusion: The findings suggest that serum sodium levels may not be a reliable biomarker for assessing the severity of preeclampsia in pregnant women, highlighting the need for further research to explore other potential indicators that could better reflect the condition’s severity and inform clinical management strategies.
- Open Access
- 16 February 2025
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
- Vol. 11 (2) , e43852
Recent trends in osteoporosis among postmenopausal women
Osteoporosis is considered by reduced bone mineral density and deteriorated bone microarchitecture, addressing the risk of fractures. Studies indicate that loss of estrogen can accelerate bone turnover, with one epidemiological study reflecting a more than two-fold increase in osteoporosis prevalence around menopausal period. Fractures associated with osteoporosis typically occur in the hip, spine, and wrist, significantly affecting mobility and quality of life. Additionally, the concept of osteoimmunology explains the reciprocal relationship between the immune system and bone health, showcasing how immune cells influence bone remodeling processes. It has been shown that inflammation-mediated pathways can lead to enhanced osteoclastogenesis as the process through which bone-resorbing cells named as osteoclasts are formed and culminating in the loss of bone mass.
- 16 February 2025
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
- Vol. 11 (2) , e43852
Open AccessRecent trends in osteoporosis among postmenopausal women
Osteoporosis is considered by reduced bone mineral density and deteriorated bone microarchitecture, addressing the risk of fractures. Studies indicate that loss of estrogen can accelerate bone turnover, with one epidemiological study reflecting a more than two-fold increase in osteoporosis prevalence around menopausal period. Fractures associated with osteoporosis typically occur in the hip, spine, and wrist, significantly affecting mobility and quality of life. Additionally, the concept of osteoimmunology explains the reciprocal relationship between the immune system and bone health, showcasing how immune cells influence bone remodeling processes. It has been shown that inflammation-mediated pathways can lead to enhanced osteoclastogenesis as the process through which bone-resorbing cells named as osteoclasts are formed and culminating in the loss of bone mass.
- Open Access
- 10 February 2025
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
- Vol. 11, e43836
Assessment of anthropometric indices in women with polycystic ovary syndrome and their correlation with high-sensitivity C-reactive protein levels; a descriptive-analytical study
Introduction: Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder among women of reproductive age, often associated with metabolic and inflammatory complications. Objectives: This study aims to evaluate the association between anthropometric parameters and high-sensitivity C-reactive protein (hs-CRP) levels, a marker of systemic inflammation, in women with PCOS. Patients and Methods: This descriptive-analytical study involved 139 women diagnosed with PCOS and referred to Firouzabadi Hospital in Tehran between November 2021 and June 2022. Participants aged 15 to 45 years were included based on a definitive diagnosis of PCOS. Data were collected using a checklist that recorded demographic information and anthropometric measurements, including body mass index (BMI), waist circumference (WC), hip circumference, and waist-to-hip ratio (WHR). Additionally, hs-CRP was measured using venous blood samples in the laboratory. The primary outcome was evaluating the correlation between the anthropometric indices and serum hs-CRP concentration in women with PCOS. Results: The results demonstrated significant correlations between hs-CRP levels and various anthropometric indices, comprising age, BMI, WC, and hip circumference. Each of these indices was positively associated with elevated hs-CRP levels, indicating that increases in these measurements corresponded to a higher likelihood of elevated hs-CRP. Additionally, the diagnostic accuracy of these anthropometric indices in predicting high hs-CRP levels indicated that WC exhibited the highest area under the curve (AUC), indicating superior predictive capability among the indices evaluated. The other anthropometric indices showed average sensitivity and specificity. Conclusion: In conclusion, the results reveal a significant relationship between hs-CRP levels and various anthropometric indices, incorporating age, BMI, WC, and hip circumference. The findings highlight anthropometric indices as the significant predictor of elevated hs-CRP levels, emphasizing its importance in clinical assessments. These insights support the routine monitoring of anthropometric indices to identify individuals at risk for inflammation-related health issues, particularly in women with PCOS.
- 10 February 2025
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
- Vol. 11, e43836
Open AccessAssessment of anthropometric indices in women with polycystic ovary syndrome and their correlation with high-sensitivity C-reactive protein levels; a descriptive-analytical study
Introduction: Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder among women of reproductive age, often associated with metabolic and inflammatory complications. Objectives: This study aims to evaluate the association between anthropometric parameters and high-sensitivity C-reactive protein (hs-CRP) levels, a marker of systemic inflammation, in women with PCOS. Patients and Methods: This descriptive-analytical study involved 139 women diagnosed with PCOS and referred to Firouzabadi Hospital in Tehran between November 2021 and June 2022. Participants aged 15 to 45 years were included based on a definitive diagnosis of PCOS. Data were collected using a checklist that recorded demographic information and anthropometric measurements, including body mass index (BMI), waist circumference (WC), hip circumference, and waist-to-hip ratio (WHR). Additionally, hs-CRP was measured using venous blood samples in the laboratory. The primary outcome was evaluating the correlation between the anthropometric indices and serum hs-CRP concentration in women with PCOS. Results: The results demonstrated significant correlations between hs-CRP levels and various anthropometric indices, comprising age, BMI, WC, and hip circumference. Each of these indices was positively associated with elevated hs-CRP levels, indicating that increases in these measurements corresponded to a higher likelihood of elevated hs-CRP. Additionally, the diagnostic accuracy of these anthropometric indices in predicting high hs-CRP levels indicated that WC exhibited the highest area under the curve (AUC), indicating superior predictive capability among the indices evaluated. The other anthropometric indices showed average sensitivity and specificity. Conclusion: In conclusion, the results reveal a significant relationship between hs-CRP levels and various anthropometric indices, incorporating age, BMI, WC, and hip circumference. The findings highlight anthropometric indices as the significant predictor of elevated hs-CRP levels, emphasizing its importance in clinical assessments. These insights support the routine monitoring of anthropometric indices to identify individuals at risk for inflammation-related health issues, particularly in women with PCOS.
- Open Access
- 17 January 2024
- Published by Brieflands in Health Scope
- Vol. 13 (1)
Social Determinants of Women's Reproductive Health: A Systematic Review
Context: Health, in all its aspects, is an important human right. There are various factors for the health of individuals with complex relationships with other cultural and social characteristics of a society that lead to inequality in health. Social determinants of health have a critical role in health matters; their impact on women's fertility and childbearing must be viewed as an important field to macrolevel and microlevel health scope decision-making and policy development. Objectives: This study aims to extract and determine the social determinants that affect women's reproductive health based on existing studies and strong evidence. Methods: This study was a systematic review that searched reputable medical databases and sites, including PubMed, Scopus, ISI, IranDoc, and SID, utilizing keywords like "social," "reproductive health/fertility/childbearing," and "women/female/woman". The scope of the study was limited to articles published between 2010 and 2019 due to the large volume of data available, and articles written in languages other than English or Persian were excluded from the review. The segregated articles concerning the abstract content were screened by two independent individuals to match the research objectives and keywords. The relevant abstracts were separated for review in the next step, and the full text of the obtained articles was read separately by two independent individuals to ensure their alignment with the research objectives. The articles were reviewed for quality and accuracy using the CASP tool, and those scoring above 75% entered the final stage of the study. Results: In the initial database search, 1731 articles were found, and after removing duplicates, 1516 remained. Of these, 1313 were removed for not meeting the research objectives, leaving 203 articles for the next stage. After further review, 92 articles were excluded, resulting in 107 articles for further review. Out of these, 84 articles were evaluated for compliance with research objectives, with 26 articles entering the critical evaluation stage. All articles scored above 75% on evaluation tools and entered the final stage of information extraction. Conclusions: The social determinants that impact women's reproductive health and childbearing, based on studies worldwide, include racial, ethnic, and national discrimination (for immigrants and minorities), micro and macroeconomic factors (income, costs of living, and healthcare), socio-cultural factors (education, employment, family norms), and socio-geographical factors (residence and urban status).
- 17 January 2024
- Published by Brieflands in Health Scope
- Vol. 13 (1)
Open AccessSocial Determinants of Women's Reproductive Health: A Systematic Review
Context: Health, in all its aspects, is an important human right. There are various factors for the health of individuals with complex relationships with other cultural and social characteristics of a society that lead to inequality in health. Social determinants of health have a critical role in health matters; their impact on women's fertility and childbearing must be viewed as an important field to macrolevel and microlevel health scope decision-making and policy development. Objectives: This study aims to extract and determine the social determinants that affect women's reproductive health based on existing studies and strong evidence. Methods: This study was a systematic review that searched reputable medical databases and sites, including PubMed, Scopus, ISI, IranDoc, and SID, utilizing keywords like "social," "reproductive health/fertility/childbearing," and "women/female/woman". The scope of the study was limited to articles published between 2010 and 2019 due to the large volume of data available, and articles written in languages other than English or Persian were excluded from the review. The segregated articles concerning the abstract content were screened by two independent individuals to match the research objectives and keywords. The relevant abstracts were separated for review in the next step, and the full text of the obtained articles was read separately by two independent individuals to ensure their alignment with the research objectives. The articles were reviewed for quality and accuracy using the CASP tool, and those scoring above 75% entered the final stage of the study. Results: In the initial database search, 1731 articles were found, and after removing duplicates, 1516 remained. Of these, 1313 were removed for not meeting the research objectives, leaving 203 articles for the next stage. After further review, 92 articles were excluded, resulting in 107 articles for further review. Out of these, 84 articles were evaluated for compliance with research objectives, with 26 articles entering the critical evaluation stage. All articles scored above 75% on evaluation tools and entered the final stage of information extraction. Conclusions: The social determinants that impact women's reproductive health and childbearing, based on studies worldwide, include racial, ethnic, and national discrimination (for immigrants and minorities), micro and macroeconomic factors (income, costs of living, and healthcare), socio-cultural factors (education, employment, family norms), and socio-geographical factors (residence and urban status).
- Open Access
- 31 October 2023
- Published by Elsevier in Bone Reports
- Vol. 19, 101722
Frailty syndrome in women with osteoporosis, should physicians consider screening? A cross-sectional study
- 31 October 2023
- Published by Elsevier in Bone Reports
- Vol. 19, 101722
Open AccessFrailty syndrome in women with osteoporosis, should physicians consider screening? A cross-sectional study
- Open Access
- 20 March 2023
- Published by Academic World Research in Medical Journal of the Islamic Republic Of Iran
- Vol. 37 (1) , 82-87
Intravaginal Isoniazid (INH) and Sublingual Misoprostol Versus Sublingual Misoprostol Alone for First-Trimester Induced Abortion: A Randomized Controlled Trial
Background: This study aimed to compare sublingual misoprostol alone or combined with vaginal Isoniazid (INH) for first-trimester abortion. Methods: In this randomized controlled trial, 80 pregnant women with missed abortion candidates for first-trimester abortion were randomly assigned to two groups. The first group received 800 μg sublingual misoprostol every ...
- 20 March 2023
- Published by Academic World Research in Medical Journal of the Islamic Republic Of Iran
- Vol. 37 (1) , 82-87
Open AccessIntravaginal Isoniazid (INH) and Sublingual Misoprostol Versus Sublingual Misoprostol Alone for First-Trimester Induced Abortion: A Randomized Controlled Trial
Background: This study aimed to compare sublingual misoprostol alone or combined with vaginal Isoniazid (INH) for first-trimester abortion. Methods: In this randomized controlled trial, 80 pregnant women with missed abortion candidates for first-trimester abortion were randomly assigned to two groups. The first group received 800 μg sublingual misoprostol every ...
- Open Access
- 2 January 2022
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 12 (1)
Renal vein thrombosis in a recent COVID-19 patient; a case report
We report a 74-year-old male with a recent history of COVID-19 pneumonia who was admitted with acute periumbilical and left lower quadrant pain and respiratory distress. Laboratory data showed pre-renal azotemia and microscopic hematuria. An abdominopelvic computerized tomography (CT) scan with intravenous contrast was conducted, showing signs of right renal vein thrombosis (RVT) with extension to inferior vena cava (IVC), without any evidence of renal ischemia. The patient did not have any risk factors for thrombosis except for probable hypercoagulopathy due to COVID-19 and diabetes mellitus. He was not an appropriate candidate for surgical or radiologic thrombectomy, thus received heparin infusion accordingly. Unfortunately, he died after the cardiopulmonary arrest on the second day of admission. Considering his respiratory distress, we suspect pulmonary embolism as the most probable cause of death.
- 2 January 2022
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 12 (1)
Open AccessRenal vein thrombosis in a recent COVID-19 patient; a case report
We report a 74-year-old male with a recent history of COVID-19 pneumonia who was admitted with acute periumbilical and left lower quadrant pain and respiratory distress. Laboratory data showed pre-renal azotemia and microscopic hematuria. An abdominopelvic computerized tomography (CT) scan with intravenous contrast was conducted, showing signs of right renal vein thrombosis (RVT) with extension to inferior vena cava (IVC), without any evidence of renal ischemia. The patient did not have any risk factors for thrombosis except for probable hypercoagulopathy due to COVID-19 and diabetes mellitus. He was not an appropriate candidate for surgical or radiologic thrombectomy, thus received heparin infusion accordingly. Unfortunately, he died after the cardiopulmonary arrest on the second day of admission. Considering his respiratory distress, we suspect pulmonary embolism as the most probable cause of death.